Hi! I'm Brian.

Nice to Meet you.

My name is Brian Roden, and I have dedicated more than three decades of my professional life to the pharmaceutical industry, working steadfastly at the intersection of scientific innovation, environmental stewardship, and business growth. Over the past twenty years, I have honed my expertise in human health and environmental sciences, leveraging my skills as a scientific consultant across the pharmaceutical and chemical sectors. In this capacity, I have led complex risk assessments, guided site investigations, and managed remediation efforts, while also providing litigation support that has informed key regulatory decisions.

Throughout my career, I have developed a reputation as a resourceful and pragmatic leader who excels in dynamic, high-pressure environments. I pride myself on my ability to bring together diverse teams, building a cohesive vision that maximizes the potential of each contributor. Whether identifying strategic opportunities for growth, forging impactful relationships with clients and government agencies, or advocating for sustainable solutions, I strive to transform challenges into pathways toward innovation and excellence.

My work has given me a deep appreciation for the delicate balance of protecting human health, safeguarding the environment, and advancing industrial progress. As an industry thought leader, I have continually sought to elevate the customer experience, pioneering approaches that not only meet current standards but also shape the future of best practices in our field.

Beyond my professional endeavors, I find purpose and grounding in my personal life. I am proud to share my journey with my wife, Carla, and together we are blessed with five wonderful children who inspire me to stay curious, compassionate, and forward-looking. Our home is also filled with the joyful energy of six dogs, whose playful presence reminds me daily of the importance of stewardship, care, and nurturing environments—values that resonate both at home and in my professional sphere.

As I look toward the future, I remain committed to leading with vision, integrity, and pragmatism, forging paths that ensure sustainable growth, excellence in service, and enduring positive impacts on human and environmental health.

MY STRENGTHS

Passion

I love to build things. Whether helping a client develop a new pharmaceutical product, assisting with M&A support, or simply making something in my home woodshop, I want to build things.

Contribution

I want to lead teams creating opportunities to make the world better by giving people the chance to live their best lives in the best of health.

Assertive

I'm not afraid to ask tough questions and have the difficult conversations to help my clients reach their goals.

MY EXPERIENCE

GreenField Chemical, Inc., Owner/Director

May 1999 - Present

Developing CMC packages for IND, NDA, and ANDA products for small, VC-funded pharmaceutical companies. Creating global supply chains that deliver speed, value, and quality.

Bright Star Enterprises, LLC, Co-Owner/Director

January 2011 - Present

Identifying, acquiring and managing investment properties

Newport Strategies, Consultant

May 1999 - August 2000

Data management and pharmaceutical market intelligence company offering lifecycle management consulting services to major pharma.

Abbott Laboratories, Inc.

August 1990 - May 1999
  • Research and development of clinical pharmaceutical product candidates
  • Drug substance commercial manufacturing management
  • Supply chain development: $250 million of commercial purchases supporting $5 billion in commercial products

EDUCATION

Lake Forest Graduate School of Management

MBA in Organizational Management June 2001

Ohio State University

Post-doctoral research 1989 - 1990

AWARDS

Chairman Award, Abbott Laboratories

1997 and 1998 for cost savings

Case Western Reserve University

PhD Organic Chemistry June 1989

Wittenberg University

BA Chemistry June 1985

PUBLICATIONS AND PATENTS

Publications

Roden, Brian A. "Thionocarbonates." Encyclopedia of Reagents for Organic Synthesis (2001).

Roden, B. A. “Hydrazine.” Encyclopedia of Reagents for Organic Synthesis (2001).

Roden, B. A. “Ethyl Iodide.“ Encyclopedia of Reagents for Organic Synthesis (2001).

Roden, B. A. (2001). Methyl Diethylamidosulfite. Encyclopedia of Reagents for Organic Synthesis.

Roden, B. A., & Gunasekera, D. (2001). Zinc–1, 2‐Dibromoethane. Encyclopedia of Reagents for Organic Synthesis, 1-1.

Shelat, Bhadra, and Brian A. Roden. "Silver (I) Benzoate." Encyclopedia of Reagents for Organic Synthesis (2001).

Balmer, M. K., Roden, B. A., Seapy, D. G., & Ladd, C. L. (2001). Silver (I) Acetate. Encyclopedia of Reagents for Organic Synthesis, 1-9.

Roden, B. A. (2001). Thionocarbonates. Encyclopedia of Reagents for Organic Synthesis.

Stoner, E. J., Roden, B. A., & Chemburkar, S. (1997). Substituted 2, 3-dihydroisoxazoles (Δ4-isoxazolines) via palladium-mediated cyclization of propargylic N-hydroxyureas. Tetrahedron letters, 38(28), 4981-4984.

STONER, E., COTHRON, D., BALMER, M., & RODEN, B. (1995, April). TMSI MEDIATED BENZYLATION VIA TANDEM ACYLATION-REDUCTION. In ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY (Vol. 209, pp. 491-ORGN). PO BOX 57136, WASHINGTON, DC 20037-0136: AMER CHEMICAL SOC.

Stoner, E. J., Cothron, D. A., Balmer, M. K., & Roden, B. A. (1995). Benzylation via Tandem Grignard reaction—iodotrimethylsilane (TMSI) mediated reduction. Tetrahedron, 51(41), 11043-11062.

Roden, B. A., Chemburkar, S., Freiberg, L., Ku, Y. Y., & Pariza, R. (1995). Synthesis of the macrolide antibiotic, oxolide. Bioorganic & Medicinal Chemistry Letters, 12(5), 1307-1310.

KU, Y., PATEL, R., RODEN, B., & SAWICK, D. (1994, March). A SIMPLE METHOD FOR THE INTRODUCTION OF THE N-HYDROXYUREA FUNCTIONALITY. In ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY (Vol. 207, pp. 120-ORGN). 1155 16TH ST, NW, WASHINGTON, DC 20036: AMER CHEMICAL SOC.

Patents

Roden, B. A., Beinat, C., Clanton, R., Marcus, S., deSouza, M., RADIOLABELED 5-AMINOLEVULINIC ACID, U.S. Provisional Patent Application No. 63/555,574 filed on February 20, 2024.

Dickman, D. A., Horrom, B. W., Roden, B. A., & Chemburkar, S. R. (1992). U.S. Patent No. 5,169,961. Washington, DC: U.S. Patent and Trademark Office.

How can I help?